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molecule kinase inhibitors against PDGF, VEGF and TGFβ 
receptors were administered orally either as single agents or 
in combination approaches. Survival and treatment-related 
side effects were followed up for more than 6 months. Lung 
density and septal fibroses were measured at various time 
points by HR-CT and MRI, and the molecular changes of 
irradiated lung tissue were analyzed using 
immunohistochemistry and gene expression analyses. 
 
Results: Treatment with individual inhibitors attenuated 
radiation-induced pulmonary inflammation, and reduced 
radiological and histological signs of pulmonary injury and 
fibrosis. Multi-pathway inhibition resulted in a significant 
additional attenuation of radiation-induced pulmonary 
damage and increased overall survival of treated mice 
compared to single-agent inhibition. Irradiation induced gene 
expression changes in lung tissue of downstream genes in 
particular for PDGF and TGFβ pathways; kinase inhibitors 
altered the expression of downstream proteins suggesting 
significant crosstalk between pathways during the 
development of radiation-induced lung injury. The expression 
of osteopontin as an established biomarker for pulmonary 
fibrosis was significantly upregulated by irradiation both on 
mRNA and protein levels; multi pathway inhibition 
completely normalized its overexpression when administered 
after radiation therapy. 
 
Conclusion: Multi-pathway signaling inhibition for PDGF, 
VEGF and TGFβ was shown to be an effective treatment for 
radiation-induced pulmonary damage and correlated well 
with reduced immune cell influx and expression of the 
pulmonary fibrosis biomarker osteopontin. Microarray-based 
gene expression analysis suggested extensive crosstalk 
between pathways upon thoracic Irradiation, warranting a 
combined Treatment approach. Multi-pathway inhibition 
suggests a novel treatment approach for the therapy of 
fibrotic lung diseases. 
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Purpose or Objective: During treatment of cancer patients 
using proton therapy, neutrons are generated as unwanted 
by-products. This out-of-field neutron exposure may affect 
the whole body of the patients and has been suggested to 
lead to enhanced formation of secondary cancer, especially 
in young patients. In recent years, indications for the 
involvement of stem cells in carcinogenesis have been 
increasing. Due to their long life span, stem cells may have 
an increased propensity to accumulate genetic damage 
relative to differentiated cells. Against this background, the 
intention of this study is to estimate the risks from neutrons 
compared to photons. Therefore, the investigation of damage 
induction on healthy adult stem cells from breast and thyroid 
tissue as an evidence of relative carcinogenic effectiveness 
following low and intermediate doses from neutrons 
compared to photons is performed. 
 
Material and Methods: Human breast cells with stem cell 
potential as well as murine thyroid stem cells are exposed to 
x-rays or neutrons (monoenergetic 0.56 MeV and 1.2 MeV 
neutron fields, neutron field with a broad energy distribution 
and a mean energy of 5 MeV) at various dose rates. In order 
to detect early indicators of carcinogenic modifications 
various in vitro analyses are utilised. By means of xenograft 
mouse models, tumour transformation for both cell types is 
analysed in vivo. 
 
Results: Previous results for cells originated from breast 
tissue show significant differences in survival, DNA repair and 
in the expression of stem cell marker MUC-1 and genes 
commonly associated with cancer following neutron 
exposure. The influence of radiation quality on the ability for 
self-renewal could be demonstrated by the use of a spheres 
formation assay. By analysing residual double strand breaks 
via the γH2AX assay, an effect on DNA repair could be 
observed, particularly after irradiation with neutrons with a 
low energy of 0.56 MeV. Furthermore the expression of the 
proteins p53, p27 and RB1 is modified considerably due to 
neutron irradiation. Similarly, exposure of thyrosphere 
derived cells showed differences in stem cell survival and 
remaining γH2AX foci after 24 hours. Long term passaging 
revealed changes in growth speed, stem cell marker 
expression and cancer associates genes changed in individual 
samples. 
 
Conclusion: Summing up, the study of stem cell behaviour 
may be a valuable tool in the investigation of carcinogenesis 
induced by ionizing radiation. The evaluation of the Relative 
Biological Effectiveness (RBE) of different types and energies 
of radiation may have a strong impact on our knowledge 
about the role of stem cells in carcinogenesis and will provide 
great benefit on the understanding of long-term risks of 
secondary cancers following low-dose exposure to neutrons 
during proton therapy.  
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Purpose or Objective: Targeted therapies like immune 
checkpoint inhibitors are rapidly turning out to be important 
assets in the treatment of non-small scell lung cancer 
(NSCLC). The expression of these genes in both tumor and the 
surrounding non-malignant lung tissue might play an 
important role in determining their therapeutic window. This 
project aims to identify different expression patterns of 
these target genes. We therefore performed transcriptome 
analysis and investigated correlations with histology, gender, 
age, CRP level and smoking status in primary resected NSCLC 
and the surrounding non-malignant lung of the same patient. 
Additionally, differentially methylated gene sites were 
checked for impact on gene regulation.  
 
Material and Methods: Tissue of primary tumor as well as 
distant lung tissue was collected from 25 untreated, primary 
resected NSCLC patients. Illumina HiSeq 2000 was used to 
determine the differential gene expression between different 
conditions for 14 different target genes. DeSeq was chosen as 
the definitive method for statistical analysis. Differential 
methylation status was analyzed on an Infinium 
HumanMethylation 450K BeadChip. Differential gene 
expression and methylation status of the 14 chosen target 
genes were compared for 11 different conditions; results with 
P-values <0.05 after Benjamini-Hochberg correction were 
considered significant. For each differentially expressed 
gene, the locations of differentially methylated sites were 
checked in the UCSC Genome Browser. Histone markers 
